| ATC code J: Antiinfectives for systemic use |
|---|
|
| Human only |
| ATCvet only |
|
| Other ATC codes |
ATCvet code QJ54 Antimycobacterials for intramammary use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products for veterinary use. Subgroup QJ54 is part of the anatomical group QJ Antiinfectives for systemic use.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
QJ54A Drugs for mycobacterial infections
QJ54AB Antibiotics
- QJ54AB02 Rifampicin
- QJ54AB03 Rifamycin
References
- "The ATCvet classification system" (PDF). European Medicines Agency. Retrieved 1 February 2020.
- "ATCvet Code, ein Klassierungssystem für Tierarzneimittel" (in German). University of Zurich. Retrieved 1 February 2020.
- "ATCvet Index 2022: code QJ54". WHO Collaborating Centre for Drug Statistics Methodology.
| Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nucleic acid inhibitor |
| ||||||||
| Protein synthesis inhibitor |
| ||||||||
| Cell envelope antibiotic |
| ||||||||
| Other/unknown | |||||||||
| Combinations | |||||||||
| |||||||||